Investors purchased shares of Johnson & Johnson (NYSE:JNJ) on weakness during trading on Thursday. $253.22 million flowed into the stock on the tick-up and $170.59 million flowed out of the stock on the tick-down, for a money net flow of $82.63 million into the stock. Of all stocks tracked, Johnson & Johnson had the highest net in-flow for the day. Johnson & Johnson traded down ($0.59) for the day and closed at $120.72

A number of research analysts recently issued reports on the stock. BTIG Research downgraded shares of Johnson & Johnson from a “buy” rating to a “neutral” rating in a research report on Thursday, May 12th. Morgan Stanley reiterated a “hold” rating on shares of Johnson & Johnson in a research report on Thursday, May 19th. Wells Fargo & Co. reiterated a “buy” rating on shares of Johnson & Johnson in a research report on Monday, July 11th. BMO Capital Markets reiterated an “outperform” rating and issued a $132.00 price objective on shares of Johnson & Johnson in a research report on Wednesday, July 20th. Finally, Zacks Investment Research upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $139.00 price objective for the company in a research report on Friday, August 5th. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and eleven have issued a buy rating to the company. Johnson & Johnson presently has an average rating of “Hold” and a consensus target price of $119.30.

The company has a market cap of $328.09 billion and a PE ratio of 22.35. The company has a 50-day moving average of $123.44 and a 200 day moving average of $113.62.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.68 by $0.06. The company earned $18.50 billion during the quarter, compared to analyst estimates of $17.98 billion. Equities research analysts anticipate that Johnson & Johnson will post $6.69 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 19th. Investors of record on Friday, August 5th will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.96%.

In other Johnson & Johnson news, CAO Ronald A. Kapusta sold 3,000 shares of Johnson & Johnson stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $115.79, for a total transaction of $347,370.00. Following the completion of the transaction, the chief accounting officer now owns 28,725 shares in the company, valued at $3,326,067.75. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Ronald A. Kapusta sold 2,935 shares of Johnson & Johnson stock in a transaction dated Friday, July 22nd. The stock was sold at an average price of $125.01, for a total transaction of $366,904.35. Following the transaction, the chief accounting officer now owns 28,660 shares of the company’s stock, valued at approximately $3,582,786.60. The disclosure for this sale can be found here.

A number of institutional investors have made changes to their positions in JNJ. Schwab Charles Investment Management Inc. boosted its position in shares of Johnson & Johnson by 5.6% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 9,788,013 shares of the company’s stock worth $1,005,425,000 after buying an additional 518,746 shares during the last quarter. Farr Miller & Washington LLC DC boosted its position in shares of Johnson & Johnson by 1.1% in the fourth quarter. Farr Miller & Washington LLC DC now owns 322,049 shares of the company’s stock worth $33,081,000 after buying an additional 3,621 shares during the last quarter. Frontier Investment Mgmt Co. boosted its position in shares of Johnson & Johnson by 0.7% in the fourth quarter. Frontier Investment Mgmt Co. now owns 152,621 shares of the company’s stock worth $15,675,000 after buying an additional 1,123 shares during the last quarter. King Luther Capital Management Corp boosted its position in shares of Johnson & Johnson by 6.9% in the fourth quarter. King Luther Capital Management Corp now owns 945,503 shares of the company’s stock worth $97,122,000 after buying an additional 60,862 shares during the last quarter. Finally, Autus Asset Management LLC boosted its position in shares of Johnson & Johnson by 55.2% in the fourth quarter. Autus Asset Management LLC now owns 32,250 shares of the company’s stock worth $3,313,000 after buying an additional 11,469 shares during the last quarter.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.